Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials

Abstract

The efficacies associated with PD-1/PD-L1 monotherapy vary significantly across cancer types and PD-L1 expression. This comprehensive summary of clinical benefit from immunotherapy in cancer patients provides an important guide for clinicians.